288 related articles for article (PubMed ID: 14613973)
1. Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity.
Ibrahimi OA; Zhang F; Eliseenkova AV; Linhardt RJ; Mohammadi M
Hum Mol Genet; 2004 Jan; 13(1):69-78. PubMed ID: 14613973
[TBL] [Abstract][Full Text] [Related]
2. Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes.
Bellus GA; Gaudenz K; Zackai EH; Clarke LA; Szabo J; Francomano CA; Muenke M
Nat Genet; 1996 Oct; 14(2):174-6. PubMed ID: 8841188
[TBL] [Abstract][Full Text] [Related]
3. Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities.
Ibrahimi OA; Zhang F; Eliseenkova AV; Itoh N; Linhardt RJ; Mohammadi M
Hum Mol Genet; 2004 Oct; 13(19):2313-24. PubMed ID: 15282208
[TBL] [Abstract][Full Text] [Related]
4. Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand.
Anderson J; Burns HD; Enriquez-Harris P; Wilkie AO; Heath JK
Hum Mol Genet; 1998 Sep; 7(9):1475-83. PubMed ID: 9700203
[TBL] [Abstract][Full Text] [Related]
5. Negative autoregulation of fibroblast growth factor receptor 2 expression characterizing cranial development in cases of Apert (P253R mutation) and Pfeiffer (C278F mutation) syndromes and suggesting a basis for differences in their cranial phenotypes.
Britto JA; Moore RL; Evans RD; Hayward RD; Jones BM
J Neurosurg; 2001 Oct; 95(4):660-73. PubMed ID: 11596961
[TBL] [Abstract][Full Text] [Related]
6. [From gene to disease; craniosynostosis syndromes due to FGFR2-mutation].
van Ravenswaaij-Arts CM; van den Ouweland AM; Hoogeboom AJ; Herbergs J; Pals G
Ned Tijdschr Geneeskd; 2002 Jan; 146(2):63-6. PubMed ID: 11820058
[TBL] [Abstract][Full Text] [Related]
7. Description of a new mutation and characterization of FGFR1, FGFR2, and FGFR3 mutations among Brazilian patients with syndromic craniosynostoses.
Passos-Bueno MR; Sertié AL; Richieri-Costa A; Alonso LG; Zatz M; Alonso N; Brunoni D; Ribeiro SF
Am J Med Genet; 1998 Jul; 78(3):237-41. PubMed ID: 9677057
[TBL] [Abstract][Full Text] [Related]
8. Craniosynostosis associated with FGFR3 pro250arg mutation results in a range of clinical presentations including unisutural sporadic craniosynostosis.
Reardon W; Wilkes D; Rutland P; Pulleyn LJ; Malcolm S; Dean JC; Evans RD; Jones BM; Hayward R; Hall CM; Nevin NC; Baraister M; Winter RM
J Med Genet; 1997 Aug; 34(8):632-6. PubMed ID: 9279753
[TBL] [Abstract][Full Text] [Related]
9. Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome.
Yu K; Herr AB; Waksman G; Ornitz DM
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14536-41. PubMed ID: 11121055
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome.
Ibrahimi OA; Eliseenkova AV; Plotnikov AN; Yu K; Ornitz DM; Mohammadi M
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7182-7. PubMed ID: 11390973
[TBL] [Abstract][Full Text] [Related]
11. Syndromic craniosynostosis: from history to hydrogen bonds.
Cunningham ML; Seto ML; Ratisoontorn C; Heike CL; Hing AV
Orthod Craniofac Res; 2007 May; 10(2):67-81. PubMed ID: 17552943
[TBL] [Abstract][Full Text] [Related]
12. Clinical study and some molecular features of Mexican patients with syndromic craniosynostosis.
Ibarra-Arce A; Almaraz-Salinas M; Martínez-Rosas V; Ortiz de Zárate-Alarcón G; Flores-Peña L; Romero-Valdovinos M; Olivo-Díaz A
Mol Genet Genomic Med; 2020 Aug; 8(8):e1266. PubMed ID: 32510873
[TBL] [Abstract][Full Text] [Related]
13. A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures.
Zhou YX; Xu X; Chen L; Li C; Brodie SG; Deng CX
Hum Mol Genet; 2000 Aug; 9(13):2001-8. PubMed ID: 10942429
[TBL] [Abstract][Full Text] [Related]
14. Syndrome of coronal craniosynostosis with brachydactyly and carpal/tarsal coalition due to Pro250Arg mutation in FGFR3 gene.
Graham JM; Braddock SR; Mortier GR; Lachman R; Van Dop C; Jabs EW
Am J Med Genet; 1998 May; 77(4):322-9. PubMed ID: 9600744
[TBL] [Abstract][Full Text] [Related]
15. Sequence analyses and comparative modeling of fly and worm fibroblast growth factor receptors indicate that the determinants for FGF and heparin binding are retained in evolution.
Nagendra HG; Harrington AE; Harmer NJ; Pellegrini L; Blundell TL; Burke DF
FEBS Lett; 2001 Jul; 501(1):51-8. PubMed ID: 11457455
[TBL] [Abstract][Full Text] [Related]
16. Craniosynostosis and related limb anomalies.
Wilkie AO; Oldridge M; Tang Z; Maxson RE
Novartis Found Symp; 2001; 232():122-33; discussion 133-43. PubMed ID: 11277076
[TBL] [Abstract][Full Text] [Related]
17. Molecular and cellular bases of syndromic craniosynostoses.
Bonaventure J; El Ghouzzi V
Expert Rev Mol Med; 2003 Jan; 5(4):1-17. PubMed ID: 14987407
[TBL] [Abstract][Full Text] [Related]
18. Genotype-phenotype correlation for nucleotide substitutions in the IgII-IgIII linker of FGFR2.
Oldridge M; Lunt PW; Zackai EH; McDonald-McGinn DM; Muenke M; Moloney DM; Twigg SR; Heath JK; Howard TD; Hoganson G; Gagnon DM; Jabs EW; Wilkie AO
Hum Mol Genet; 1997 Jan; 6(1):137-43. PubMed ID: 9002682
[TBL] [Abstract][Full Text] [Related]
19. Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization.
Ibrahimi OA; Yeh BK; Eliseenkova AV; Zhang F; Olsen SK; Igarashi M; Aaronson SA; Linhardt RJ; Mohammadi M
Mol Cell Biol; 2005 Jan; 25(2):671-84. PubMed ID: 15632068
[TBL] [Abstract][Full Text] [Related]
20. [The molecular genetic background of hereditary craniosynostoses and chondrodysplasias].
Hertz JM; Juncker I; Christensen L; Østergaard JR; Jensen PK
Ugeskr Laeger; 2001 Sep; 163(36):4862-7. PubMed ID: 11571861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]